[Heparins and thrombocytes].
The author discusses problems of less well known and less frequent complications of preventive or curative heparin administration. Published findings pertaining to this problem are supplemented by the author's clinical experience. As regards the risk of heparin induced thrombocytopenia, administration of low molecular heparins involves a smaller risk.